A Study of Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy and Concurrent Chemotherapy

NCT00626639 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Mucositis
Head and Neck Cancer

Interventions

DRUG: Placebo
DRUG: palifermin
RADIATION: Radiotherapy
DRUG: Cisplatin

Sponsor

Swedish Orphan Biovitrum

Collaborators

[object Object]